The Juvenile Diabetes Research Foundation has presented the FDA with a petition signed by 100,000 senators, doctors and patients, urging the agency to release clear guidance to expedite its recommended device development restrictions for evaluating artificial pancreas systems. The group is expecting the FDA to issue the guidelines by Dec. 1.

Related Summaries